IP Library Granted Patent US 12,409,271
Granted Patent B2
US 12,409,271 · App. 17/660,514 · Granted Sep 9, 2025

Apparatus and method for producing an enriched medical suspension

Inventor: Frank Levy (Fort Myers, FL)
A61M5/19A61M11/007A61M25/0026A61M25/003A61M25/0068A61M25/007A61M25/0071A61M2005/1787A61M2025/0034A61M2025/0073A61M2202/04A61M2209/082
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,409,271
App. No.
17/660,514
Granted
Sep 9, 2025
Kind
B2
Abstract

A medical fluid suspension generating delivery apparatus includes a dual syringe assembly including a first receptacle for a pressurized chemical solution and a second receptacle for a medical solution. The medical fluid suspension generating delivery apparatus also includes a Venturi-agitating tip assembly generating an enriched medical suspension from the pressurized chemical solution and a second receptacle for a medical solution.

Claims (18)

1. A medical fluid suspension generating delivery apparatus, comprising:

a dual syringe assembly including a first receptacle for a pressurized chemical solution and a second receptacle for a medical solution, the first receptacle includes a cylindrical body with a first end shaped and dimensioned to receive a first plunger and a second end defining an outlet of the first receptacle, and the second receptacle includes a cylindrical body with a first end shaped and dimensioned to receive a second plunger and a second end defining an outlet of the second receptacle,

the dual syringe assembly further including an actuation member engaging the first and second plungers such that the first and second plungers are moved in a coordinated manner, the actuation member comprising a controlled actuation assembly oriented in alignment with a free end of the second plunger; and

a Venturi-agitating tip assembly generating an enriched medical suspension from the pressurized chemical solution and the medical solution;

wherein when the dual syringe assembly is filled and ready for use, the controlled actuation assembly is spaced from the free end of the second plunger, and when the actuation member is first pressed downwardly only the first plunger is moved and the second plunger is not moved until the actuation member has moved downwardly a distance sufficient to bring a second end of the controlled actuation assembly into contact with the free end of the second plunger.

2. The medical fluid suspension generating delivery apparatus according to claim 1 , wherein the dual syringe assembly includes a syringe body including a receptacle support having a first recess in which the first receptacle is mounted and a second recess in which the second receptacle is mounted.

3. The medical fluid suspension generating delivery apparatus according to claim 1 , wherein sizes of the first receptacle and the second receptacle are different.

4. The medical fluid suspension generating delivery apparatus according to claim 1 , wherein the first and second receptacles are oriented parallel to each other such that the outlets of the respective first and second receptacles are aligned for connection with respective input cannulas of a dual lumen catheter connecting the pressurized chemical solution and the medical solution to the Venturi-agitating tip assembly.

5. The medical fluid suspension generating delivery apparatus according to claim 1 , wherein the actuation member and the first and second plungers are oriented such that upon actuation a small amount the pressurized chemical solution flows through the Venturi-agitating tip assembly before the medical solution flows therethrough.

6. The medical fluid suspension generating delivery apparatus according to claim 5 , wherein the actuation member is fixedly attached to a free end of the first plunger.

7. The medical fluid suspension generating delivery apparatus according to claim 1 , wherein a cup at the free end of the second plunger fits about the second end of the controlled actuation assembly.

8. A medical fluid suspension generating delivery apparatus, comprising:

a dual syringe assembly comprising:

a first receptacle for a pressurized chemical solution and a second receptacle for a medical solution, the first receptacle includes a cylindrical body with a first end shaped and dimensioned to receive a first plunger and a second end defining an outlet of the first receptacle, and the second receptacle includes a cylindrical body with a first end shaped and dimensioned to receive a second plunger and a second end defining an outlet of the second receptacle;

the first and second receptacles are oriented parallel to each other such that the outlets of the respective first and second receptacles are aligned for connection with respective input cannulas of a dual lumen catheter connecting the pressurized chemical solution and the medical solution to a Venturi-agitating tip assembly;

the dual syringe assembly further including an actuation member engages the first and second plungers such that the first and second plungers are moved in a coordinated manner, the actuation member is fixedly attached to a free end of the first plunger and the actuation member includes a controlled actuation assembly is oriented in alignment with a free end of the second plunger;

the Venturi-agitating tip assembly generating an enriched medical suspension from the pressurized chemical solution and the medical solution;

wherein the actuation member and the first and second plungers are oriented such that upon actuation a small amount the pressurized chemical solution flows through the Venturi-agitating tip assembly before the medical solution flows therethrough and a cup at the free end of the second plunger fits about a second end of the controlled actuation assembly, wherein when the dual syringe assembly is filled and ready for use, the controlled actuation assembly is spaced from the free end of the second plunger, and when the actuation member is first pressed downwardly only the first plunger is moved and the second plunger is not moved until the actuation member has moved downwardly a distance sufficient to bring the second end of the controlled actuation assembly into contact with the free end of the second plunger.

Continuity (1)
Related Publication 20230338658A1 · Oct 26, 2023
References Cited (58)
US 3831844A · Tropeano et al. · 1974 [cited by applicant]
US 4044757A · McWhorter · 1977 [cited by examiner]
US 4219021A · Fink · 1980 [cited by applicant]
US 5154348A · Ratnik et al. · 1992 [cited by applicant]
US 5195963A · Yafuso et al. · 1993 [cited by applicant]
US 5345932A · Yafuso et al. · 1994 [cited by applicant]
US 5395318A · Kaprelian · 1995 [cited by applicant]
US 5580530A · Kowatsch et al. · 1996 [cited by applicant]
US 5699961A · Ratnik et al. · 1997 [cited by applicant]
US 5875776A · Vaghefi · 1999 [cited by applicant]
US 5964223A · Baran · 1999 [cited by applicant]
US 6164556A · Dupre et al. · 2000 [cited by applicant]
US 6402047B1 · Thomas · 2002 [cited by applicant]
US 6474091B2 · Guerra · 2002 [cited by applicant]
US 6572873B1 · Osman et al. · 2003 [cited by applicant]
US 6610033B1 · Melanson · 2003 [cited by applicant]
US 6939329B1 · Verkaart · 2005 [cited by examiner]
US 6959708B1 · Rasor et al. · 2005 [cited by applicant]
US 7543760B2 · Levy et al. · 2009 [cited by applicant]
US 7763269B2 · Wright et al. · 2010 [cited by applicant]
US 8876749B2 · Levy · 2014 [cited by applicant]
US 9744342B2 · Levy · 2017 [cited by applicant]
US 10155093B2 · Levy et al. · 2018 [cited by applicant]
US 10322271B2 · Levy et al. · 2019 [cited by applicant]
US 10350398B2 · Levy · 2019 [cited by applicant]
US 10350399B2 · Levy et al. · 2019 [cited by applicant]
US 20020174578A1 · Ross · 2002 [cited by applicant]
US 20060071091A1 · Ratnik · 2006 [cited by applicant]
US 20060074386A1 · Wollmann et al. · 2006 [cited by applicant]
US 20060178620A1 · Wollmann et al. · 2006 [cited by applicant]
US 20060253082A1 · McIntosh · 2006 [cited by examiner]
US 20070104651A1 · Wright et al. · 2007 [cited by applicant]
US 20070244429A1 · Nguyen et al. · 2007 [cited by applicant]
US 20080120992A1 · Levy et al. · 2008 [cited by applicant]
US 20080167621A1 · Wagner · 2008 [cited by examiner]
US 20090062741A1 · Smith et al. · 2009 [cited by applicant]
US 20090194453A1 · Thorne · 2009 [cited by applicant]
US 20090198211A1 · Thorne, Jr. · 2009 [cited by examiner]
US 20090198217A1 · Thorne · 2009 [cited by applicant]
US 20090264831A1 · Thompson · 2009 [cited by examiner]
US 20090318890A1 · Levy · 2009 [cited by applicant]
US 20100101579A1 · Levy · 2010 [cited by applicant]
US 20110106054A1 · Osborne · 2011 [cited by examiner]
US 20110245866A1 · Cassingham · 2011 [cited by applicant]
US 20140148791A1 · Neomend · 2014 [cited by applicant]
US 20140257179A1 · Schwab · 2014 [cited by examiner]
US 20150133779A1 · Yurek · 2015 [cited by applicant]
US 20160166782A1 · Levy · 2016 [cited by examiner]
US 20170035653A1 · Osborne · 2017 [cited by examiner]
US 20190307971A1 · Levy · 2019 [cited by applicant]
EP 246820481A1 · 2012 [cited by applicant]
EP 2548607A2 · 2013 [cited by applicant]
ES 2332032A1 · 2010 [cited by examiner]
JP 2000262525A · 2000 [cited by examiner]
WO 9300951A1 · 1993 [cited by applicant]
WO 0072821A1 · 2000 [cited by applicant]
WO 0241872A1 · 2002 [cited by applicant]
WO 2005048984A1 · 2005 [cited by applicant]